Sanctuary Advisors LLC lifted its holdings in shares of Solventum Co. (NYSE:SOLV - Free Report) by 95.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,074 shares of the company's stock after buying an additional 9,323 shares during the period. Sanctuary Advisors LLC's holdings in Solventum were worth $1,351,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Copeland Capital Management LLC bought a new stake in Solventum during the third quarter worth $26,000. Mather Group LLC. acquired a new position in shares of Solventum during the 3rd quarter worth about $27,000. Hollencrest Capital Management bought a new stake in shares of Solventum in the 2nd quarter valued at about $25,000. True Wealth Design LLC raised its holdings in shares of Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company's stock valued at $33,000 after purchasing an additional 471 shares during the period. Finally, Deseret Mutual Benefit Administrators acquired a new stake in Solventum in the 2nd quarter valued at about $25,000.
Analyst Ratings Changes
Several research firms have issued reports on SOLV. Wolfe Research initiated coverage on Solventum in a research report on Thursday, September 26th. They issued a "peer perform" rating for the company. Morgan Stanley lifted their price objective on shares of Solventum from $60.00 to $73.00 and gave the stock an "equal weight" rating in a research report on Monday, November 11th. Piper Sandler increased their price objective on shares of Solventum from $71.00 to $75.00 and gave the company a "neutral" rating in a research report on Friday, November 8th. Mizuho assumed coverage on shares of Solventum in a report on Wednesday, December 4th. They set a "neutral" rating and a $70.00 target price for the company. Finally, BTIG Research started coverage on shares of Solventum in a report on Thursday, September 5th. They issued a "neutral" rating on the stock. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Solventum has an average rating of "Hold" and an average target price of $68.29.
Check Out Our Latest Stock Analysis on Solventum
Solventum Stock Performance
SOLV stock traded up $0.03 during mid-day trading on Friday, hitting $66.83. The stock had a trading volume of 1,770,990 shares, compared to its average volume of 1,624,806. The firm has a fifty day simple moving average of $70.90 and a 200 day simple moving average of $63.55. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05.
Solventum Company Profile
(
Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Read More
Before you consider Solventum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.
While Solventum currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
